779-72-6Relevant articles and documents
TRICYCLIC COMPOUND AS CRTH2 INHIBITOR
-
Paragraph 0208; 0209, (2019/06/07)
Provided are a tricyclic compound as shown in formula (I) as a CRTH2 inhibitor, or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or a solvate thereof, and the use thereof in treating diseases related to CRTH2 receptors.
Indole derivatives with CRTH2 inhibitor activity
-
Paragraph 0107; 0110; 0111, (2018/05/16)
The invention discloses indole derivatives having CRTH2 inhibitor activity and shown as formula (I) in the description or pharmaceutically acceptable salts of the indole derivatives and an applicationof the indole derivatives to treatment of CRTH2 recepto